Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

New antifungal agents.

J L Lesher1

  • 1Department of Dermatology, Medical College of Georgia, Augusta.

Dermatologic Clinics
|October 11, 1992
PubMed
Summary
This summary is machine-generated.

Dermatologists can expect new and improved antifungal agents for skin infections. This includes updates on older drugs like ketoconazole and promising new options such as fluconazole and terbinafine.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Axillary granular parakeratosis.

International journal of dermatology·2001
Same author

Primary multiple miliary osteoma cutis and exogenous ochronosis.

Cutis·2001
Same author

A unique variant of Darier's disease.

International journal of dermatology·2001
Same author

Successful treatment of an intractable case of hereditary basal cell carcinoma syndrome with paclitaxel.

Archives of dermatology·2001
Same author

Oral therapy of common superficial fungal infections of the skin.

Journal of the American Academy of Dermatology·1999
Same author

Telemedicine evaluation of cutaneous diseases: a blinded comparative study.

Journal of the American Academy of Dermatology·1998
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Dermatology
  • Mycology
  • Pharmacology

Background:

  • Antifungal therapy is crucial for treating superficial and deep fungal infections.
  • The landscape of antifungal agents is continually evolving with new drug development.
  • Understanding the efficacy and safety profiles of existing and emerging antifungals is essential for clinical practice.

Purpose of the Study:

  • To provide an update on new information regarding older antifungal agents.
  • To review evolving data on new antifungal agents, including those in clinical trials.
  • To highlight the potential roles of emerging antifungals in dermatological practice.

Main Methods:

  • Review of current literature on antifungal agents.
  • Analysis of clinical trial data for new antifungal drugs.

Related Experiment Videos

  • Discussion of the therapeutic applications and limitations of various antifungal classes.

    • Main Results:

    • Ketoconazole remains a key dermatological antifungal, but requires monitoring for side effects and interactions.
    • Fluconazole's role in cutaneous fungal infections requires further controlled studies.
    • Itraconazole and terbinafine show promise for dermatophyte, candidal, and other challenging fungal infections.
    • Research is ongoing for other antifungal classes like piritetrate, cilofungin, and amorolfine.

    Conclusions:

    • The 1990s are anticipated to offer dermatologists safer and more effective antifungal treatments.
    • Continued research is vital for optimizing the use of antifungal agents in treating cutaneous mycoses.
    • Clinicians must stay informed about the latest advancements in antifungal drug therapy.